Chloramphenicol or chloramphenicolum

This classification denotes a protein synthesis inhibitor and antibiotic with the molecular formula C11H12Cl2N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 66974FR9Q1, chemically known as dl-threo-2,2-dichloro-n-(beta-hydroxy-alpha-hydroxymethyl-4-nitrophenethyl)acetamide but generally known as chloramphenicol, which bears US NIH Compound Identifier 298. European Medicines Agency schedules Chloramphenicol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06173MIG. The term CHLORAMPHENICOL is an International Non-Proprietary Name. World Health Organization schedules chloramphenicol in its Anatomical Therapeutic Chemical (ATC) Classification. CHLORAMPHENICOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Chloramphenicol or chloramphenicolum bears US NLM identifiers UMLS ID C0008168 and NCI Concept Code C363. SMILES: C1=CC(=CC=C1C(C(CO)NC(=O)C(CL)CL)O)[N+](=O)[O-].